Insights

Innovative Tissue Platform Fluicell's Nexocyte platform enables the development of transplantable tissues aimed at curing serious diseases such as type 1 diabetes, creating opportunities to collaborate with biotech, regenerative medicine, and pharmaceutical companies seeking cutting-edge tissue solutions.

Recent Tech Deployments The launch of Fluicell’s high-precision 3D bioprinter, Biopixlar AER, demonstrates their capability in producing detailed biological tissues, presenting potential sales avenues in bioprinting and tissue engineering markets.

Funding and Growth Recent financial support, including SEK 2.7 million in retroactive research deductions and a $261K investment, indicates ongoing growth and development potential, making the company a promising partner for investors and collaborators in biotech R&D projects.

Market Focus With ambitions to develop tissues for regenerative medicine and drug screening, Fluicell offers opportunities for partnerships with pharmaceutical firms, research institutions, and medical device companies interested in advanced testing and therapeutic solutions.

Technology Integration The company's utilization of advanced bioprinting technology and continuous product launches signal a strong innovation pipeline, ideal for engaging businesses looking for high-precision manufacturing and tissue engineering capabilities.

Fluicell AB Tech Stack

Fluicell AB uses 8 technology products and services including Open Graph, Cookiebot, Choices, and more. Explore Fluicell AB's tech stack below.

  • Open Graph
    Content Management System
  • Cookiebot
    Cookie Compliance
  • Choices
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • DataTables
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PWA
    Miscellaneous
  • HSTS
    Security

Fluicell AB's Email Address Formats

Fluicell AB uses at least 1 format(s):
Fluicell AB Email FormatsExamplePercentage
First@fluicell.comJohn@fluicell.com
70%
First.Last@fluicell.comJohn.Doe@fluicell.com
26%
Last@fluicell.comDoe@fluicell.com
4%

Frequently Asked Questions

Where is Fluicell AB's headquarters located?

Minus sign iconPlus sign icon
Fluicell AB's main headquarters is located at 8c Flöjelbergsgatan Mölndal, Västra Götaland 431 37 Sweden. The company has employees across 1 continents, including Europe.

What is Fluicell AB's phone number?

Minus sign iconPlus sign icon
You can contact Fluicell AB's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fluicell AB's stock symbol?

Minus sign iconPlus sign icon
Fluicell AB is a publicly traded company; the company's stock symbol is FLUI.ST.

What is Fluicell AB's official website and social media links?

Minus sign iconPlus sign icon
Fluicell AB's official website is fluicell.com and has social profiles on LinkedIn.

What is Fluicell AB's SIC code NAICS code?

Minus sign iconPlus sign icon
Fluicell AB's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fluicell AB have currently?

Minus sign iconPlus sign icon
As of May 2026, Fluicell AB has approximately 16 employees across 1 continents, including Europe. Key team members include Chief Technology Officer: G. D. M. J.Chief Marketing And Communications Officer: J. H.Chief Financial Officer: J. W.. Explore Fluicell AB's employee directory with LeadIQ.

What industry does Fluicell AB belong to?

Minus sign iconPlus sign icon
Fluicell AB operates in the Biotechnology Research industry.

What technology does Fluicell AB use?

Minus sign iconPlus sign icon
Fluicell AB's tech stack includes Open GraphCookiebotChoicesModernizrDataTablesLodashPWAHSTS.

What is Fluicell AB's email format?

Minus sign iconPlus sign icon
Fluicell AB's email format typically follows the pattern of First@fluicell.com. Find more Fluicell AB email formats with LeadIQ.

When was Fluicell AB founded?

Minus sign iconPlus sign icon
Fluicell AB was founded in 2012.

Fluicell AB

Biotechnology ResearchVästra Götaland, Sweden11-50 Employees

Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable our world-leading partners to advance their drug-screening capabilities for the development of game-changing medicines.

Section iconCompany Overview

Headquarters
8c Flöjelbergsgatan Mölndal, Västra Götaland 431 37 Sweden
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
FLUI.ST
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconFunding & Financials

  • $1M

    Fluicell AB's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Fluicell AB's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.